Both Objective and Subjective Measures Needed to Measure Disability in DMD
Both objective and subjective measures of disability in Duchenne muscular dystrophy can help physicians better care for their patients.
Both objective and subjective measures of disability in Duchenne muscular dystrophy can help physicians better care for their patients.
It is unfortunate that the prevailing view on chronic illness is that it simply “happens” to someone, and that the best one can do is to cope with the difficulties attached, comply with treatment, and hope for the best. This is perhaps exacerbated by medical language; a patient is said to have been “diagnosed with”…
Some therapeutic advancements are so central to the diseases they treat that they themselves define a specific era in the therapeutic history of the disease, even as physicians continue to search for a definitive cure. Some therapeutic discoveries have redefined and reinvigorated modern medicine as we know it. Take, for example, the discovery of penicillin,…
Duchenne muscular dystrophy (DMD) can result in dysfunctional muscle stem cells, which in turn drive DMD pathology.
The remote monitoring of physical exercise among boys with Duchenne muscular dystrophy has been found to be safe and efficacious.
We explore why Duchenne muscular dystrophy is a disease that can benefit tremendously from advances in stem cell research.
Various research institutions are investing time and money to refine gene therapy as a viable treatment technique for patients with DMD.
We investigate the importance of cardiac care in DMD patients and explore how it has improved over the last few years.
We examine the lasting impact of innovative clinical trial designs for rare diseases on other clinical experiments.
Is genome editing ready for widespread use among DMD patients around the globe? We explore this question in detail.